↓ Skip to main content

Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)

Overview of attention for article published in Arthritis Research & Therapy, January 2021
Altmetric Badge

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)
Published in
Arthritis Research & Therapy, January 2021
DOI 10.1186/s13075-020-02387-6
Pubmed ID
Authors

Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka, Motohiro Oribe, Mitsuhiro Kawano, Masayuki Yokoyama, Aileen L. Pangan, Yuko Konishi, Sebastian Meerwein, Yoshiya Tanaka

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 19%
Student > Ph. D. Student 3 10%
Student > Master 2 6%
Student > Postgraduate 2 6%
Researcher 2 6%
Other 3 10%
Unknown 13 42%
Readers by discipline Count As %
Medicine and Dentistry 13 42%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Nursing and Health Professions 1 3%
Immunology and Microbiology 1 3%
Engineering 1 3%
Other 0 0%
Unknown 12 39%